United States - English - NLM (National Library of Medicine)

laon commerce co ltd - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - whitening, wrinkle care take an appropriate amount of this product and spread it evenly on the skin

United States - English - NLM (National Library of Medicine)

laon commerce co ltd - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - skin protect in the last step of basic care, apply an appropriate amount to the face, neck, arms, legs, etc. that are prone to uv exposure.

United States - English - NLM (National Library of Medicine)

laon commerce co ltd - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - skin protect take an appropriate amount of this product and spread it evenly on the skin.

United States - English - NLM (National Library of Medicine)

laon commerce co ltd - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - skin protect take an appropriate amount of essence and gently spread over the entire face for absorption.

United States - English - NLM (National Library of Medicine)

laon commerce co ltd - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - skin protect how to use; at the last stage of basic care, apply an appropriate amount to the face, neck, arms, and legs that are easily exposed to uv rays.

United States - English - NLM (National Library of Medicine)

bsg h & b co., ltd. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - brightening, anti wrinkle care apply an appropriate amount onto face and gently massage until fully absorbed

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine injection, usp is indicated for the following: conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration ). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: - second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functionin

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine injection, usp is indicated for the following: conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functio

United States - English - NLM (National Library of Medicine)

akorn - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine injection, usp is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. adenosine injection is contraindicated in patients with: - second- or third-degree av block (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - known or suspected bronchoconstrictive or bronchospastic lung disease (e.g., asthma) [see warnings and precautions (5.3)] - known hypersensitivity to adenosine injection [see warnings and precautions (5.7)] pregnancy category c . animal reproduction studies have not been conducted with adenosine; nor have studies been performed in pregnant women. because it is not known whether adenosine can cause fetal harm when administered to pregnant women, adenosine should be used during pregnancy only if clearly needed. it is not known whether adenosine is excreted in human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions from adenosine in nursing infants, the decision to interrupt nursing after administration of adenosine or not to administer adenosine, should take into account the importance of the drug to the mother. the safety and effectiveness of adenosine in patients less than 18 years of age have not been established. clinical studies with adenosine injection did not include sufficient numbers of subjects aged younger than 65 years to determine whether they respond differently. other reported experience has not revealed clinically relevant differences of the response of elderly in comparison to younger patients.

United States - English - NLM (National Library of Medicine)

mylan institutional llc - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine injection is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. adenosine is contraindicated in patients with: pregnancy category c . animal reproduction studies have not been conducted with adenosine; nor have studies been performed in pregnant women. because it is not known whether adenosine can cause fetal harm when administered to pregnant women, adenosine should be used during pregnancy only if clearly needed. it is not known whether adenosine is excreted in human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions from adenosine in nursing infants, the decision to interrupt nursing after administration of adenosine or not to administer adenosine, should take into account the importance of the drug to the mother. the safety and effectiveness of adenosine in patients less than 18 years of age have not been established. clinical studies with adenosine did not include suffic